Radiology Residency Program

The Dana-Farber Cancer Institute is designated as a comprehensive center by the National Cancer Institute (NCI). The research program based at the Dana-Farber Cancer Institute focuses on molecular imaging, the use of PET/CTs and other imaging modalities in the testing of novel molecularly-targeted drugs and new PET radiopharmaceuticals in patients with cancer. The department serves as an image analysis core laboratory for various local, national and global clinical trials. The Research Fellow will also participate in the activities of the Tumor Imaging Metrics Core, a NCI-sponsored core in the Dana-Farber/Harvard Cancer Center.

The responsibilities of the Research Fellow will include PET/CT, MRI, and CT image analysis, and other multiple research activities within our multidisciplinary group.

Eligibility:
A MD, PhD or MD/PhD, with experience in Radiology and/or Nuclear Medicine and computer image transfer and analysis is preferred. Interested applicants should send their curriculum vitae, along with the names of three contacts for references, or have the references send their letter directly to:
Annick D. Van den Abbeele, MD
Chief, Department of Radiology Dana-Farber Cancer Institute
44 Binney Street, Boston, MA 02115
Attention: Ellen Yonker
Tel: (617) 632-4891
Fax: (617) 582-8574
E-mail: ellen_yonker@dfci.harvard.edu

The Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Nuclear Medicine Oncologic Program is accepting applications from MD/MD-PhD affiliates for a one-year Nuclear Oncology/PET-CT Fellowship for July 2009 with the opportunity to extend it to a second year.

The Dana-Farber Cancer Institute is designated as a comprehensive center by the National Cancer Institute. The clinical fellowship will provide physicians with advanced clinical imaging training in oncology with a focus on PET/CT and cross-sectional imaging. Fellows also have the opportunity to participate in various clinical research projects. Major areas of interest include molecular imaging, evaluation of molecularly-targeted drugs, and new PET radiopharmaceuticals, tumor metrics, and core laboratory support for local, national, and global trials. The Dana-Farber Cancer Institute is an affiliate of the Harvard Medical School Joint Program in Nuclear Medicine.

Eligibility:
Completion of the USMLE parts I, II, and III, and American Board of Radiology (ABR) and/or American Board of Nuclear Medicine (ABNM)-eligible or certified. Interested applicants should send their curriculum vitae and the names of three contacts for references or have the references sent their letter to:
Annick D. Van den Abbeele, MD
Chief, Department of Radiology Dana-Farber Cancer Institute
44 Binney Street, Boston, MA 02115
Attention: Ellen Yonker
Tel: (617) 632-4891
Fax: (617) 582-8574
E-mail: ellen_yonker@dfci.harvard.edu

The breast-tract oncoradiology fellowship at the Dana-Farber Cancer Institute (DFCI) is a 12-month fellowship offered to board-eligible or board-certified radiologists. It provides in-depth knowledge of the multidisciplinary diagnostic approach to medical oncology, with a particular emphasis on breast imaging and intervention.

Structure:
The Chief of the Department of Radiology at the DFCI is. Annick D. Van den Abbeele, MD and the DFCI fellowship program is directed byFiona Fennessy, MD, PhD. One fellow is recruited each academic year. The oncoradiology, breast imaging fellowship at DFCI is structured in accordance with the fellowship regulations provided by the Deptartment of Radiology at Brigham and Women’s Hospital (BWH).

Rotation Overview:
Half of the oncoradiology fellowship entails body imaging. This is divided between CT, MR, with some ultrasound and plain film diagnostic studies and PET-CT. MR encompasses primarily abdominal and pelvic imaging, but also chest and musculoskeletal imaging. Nuclear oncology imaging services includes two PET-CTs, and plays an important role in cancer staging, restaging, follow-up, and monitoring of therapeutic response to standard and innovative therapies at the forefront of molecular imaging. Many of the important new therapies are being tested in clinical trials at the DFCI, and the fellow is exposed to current clinical treatments, as well as new investigational treatments including molecular-targeted therapies.
 
30% of this fellowship position focuses on breast imaging. This encompasses mammography (screening and diagnostic), MRI of the breast and image-guided interventions in the breast. Time is spent both at DFCI and BWH.

Research:
The fellow is allotted a day free of clinical responsibilities (dedicated 20% research time) to partake in a research project, in whatever area is on interest to them, mentored by a radiology attending. However, research progress is closely monitored and timeframes for advancement with the project are strictly adhered to, as outlined by the BWH radiology fellowship guidelines.

Elective Time:
There is one month of elective time. This may be spent in research, or in subspecialties such as cross-sectional interventional radiology, vascular–interventional radiology or neuroradiology at the Brigham and Women's Hospital.

Teaching:
There are many lecture series and conferences available to the fellow. Daily didactic teaching sessions are provided by the staff of the DFCI radiology department. BWH radiology noon-conferences are also available on a daily basis, although this conference time is not protected while on the clinical schedule Continual educational contact is provided 5 days a week, from 8 AM until 6 PM.

Fellowship Supervision and Evaluation:
The staff radiologists at the DFCI provide on-site training and teaching. Fellows are continually evaluated throughout the year, and are provided constant feedback.Fiona M. Fennessy,MD, PhD, Robin Birdwell, MD and Annick D. Van den Abbeele, MD oversee the fellow’s performance in the oncoradiology fellowship program.

Fiona M. Fennessy, MD, PhD
Fellowship Program Director
Department of Radiology Dana-Faber Cancer Institute
44 Binney Street, Boston, MA 02115
Attention: Ellen Yonker
Fellowship Coordinator
Tel: (617) 632-4891
Fax: (617) 582-8574
Email: ellen_yonker@dfci.harvard.edu

The oncoradiology fellowship at the Dana-Farber Cancer Institute (DFCI) is a 12-month fellowship offered to board-eligible or board-certified radiologists. It provides in-depth knowledge of the multidisciplinary diagnostic approach to medical oncology.

Structure:
The Chief of the Department of Radiology at the DFCI is Annick D. Van den Abbeele, MD and the DFCI fellowship program is directed by Fiona Fennessy, MD, PhD. Three to four fellows are recruited each academic year. The oncoradiology fellowship at DFCI is structured in accordance with the fellowship regulations provided by the Dept of Radiology at Brigham and Womens Hospital (BWH).

Rotation Overview:
Approximately 50% of the oncoradiology fellowship entails body imaging. This primarily involves CT, and MR with some ultrasound and plain film diagnostic studies. MR encompasses primarily abdominal and pelvic imaging, but also chest and musculoskeletal imaging.

30% of the fellowship is divided between nuclear oncology and consultative services. Nuclear oncology imaging services includes two PET/CTs, and plays an important role in cancer staging, restaging, follow-up, and monitoring of therapeutic response to standard and innovative therapies at the forefront of molecular imaging. Many of the important new therapies are being tested in clinical trials at the DFCI, and the fellow is exposed to current clinical treatments, as well as new investigational treatments including molecular-targeted therapies.

The consultation service is unique to the DFCI, where a radiologist provides on-site consultation services in the oncology clinics. The radiologist is an active member of the clinical team, playing an important role in the decision-making process for the patient. All patient scans including all modalities and all body parts are consulted upon.

If desired, a breast imaging rotation is also an option, though not mandatory.

Research:
The fellow is allotted a day free of clinical responsibilities (dedicated 20% research time) to partake in a research project, in whatever area is on interest to them, mentored by a radiology attending. However, research progress is closely monitored and timeframes for advancement with the project are strictly adhered to, as outlined by the BWH radiology fellowship guidelines.

Elective Time:
There is one month of elective time. That may be spent in research, or in subspecialties such as cross-sectional interventional radiology, vascular–interventional radiology or neuroradiology at the Brigham and Women's Hospital.

Teaching:
There are many lecture series and conferences available to the fellow. Daily didactic teaching sessions are provided by the staff of the DFCI Department of Radiology. BWH radiology noon-conferences are also available on a daily basis, although this conference time is not protected while on the clinical schedule Continual educational contact is provided 5 days a week, from 8 AM until 6 PM.

Congerence Responsibilities:
The DFCI Radiology Dept. expects the oncoradiology fellow to attend and present at the Thoracic oncology conference, Tuesday AM, and Radiology-Oncology pathology conference, Friday AM.

Fellowship Supervision and Evaluation:
The staff radiologists at the DFCI provide on-site training and teaching. Fellows are continually evaluated throughout the year, and are provided constant feedback. Dr. Fennessy and Dr. Van den Abbeele oversee the fellow’s performance in the oncoradiology fellowship program.

Fiona M. Fennessy, MD, PhD
Fellowship Program Director
Department of Radiology Dana-Faber Cancer Institute
44 Binney Street, Boston, MA 02115
Attention: Ellen Yonker
Fellowship Coordinator
Tel: (617) 632-4891
Fax: (617) 582-8574
Email: ellen_yonker@dfci.harvard.edu